Cybin (CBOE:HELP) Trading Down 6.3% – Should You Sell?

Cybin Inc (CBOE:HELP) shares dropped 6.3% on Thursday . The stock traded as low as C$5.37 and last traded at C$5.38. Approximately 771,245 shares changed hands during mid-day trading, The stock had previously closed at C$5.74.

Cybin Price Performance

Cybin Company Profile

Cybin (TSE: CYBN) is a clinical-stage biotechnology company focused on developing psychedelic-inspired therapeutics for the treatment of mental health disorders. The company pursues drug development programs that combine novel small-molecule compounds with proprietary formulation and delivery technologies, with the goal of producing standardized, scalable treatment options for conditions such as depression, anxiety and substance use disorders.

Cybin’s activities include preclinical research, formulation development, and conduct of Phase 1 and later-stage clinical trials to evaluate safety, tolerability and therapeutic effect.